galactosamine has been researched along with lactic acid in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (20.00) | 18.7374 |
| 1990's | 5 (33.33) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takagi, D; Takeyama, N; Tanaka, T | 1 |
| Chang, TM; Zhou, MX | 1 |
| Kizaki, Z; Kleckner, NW; Thurman, RG | 1 |
| Mori, S; Murakami, K; Yamamoto, C; Yoshino, M | 1 |
| Goto, M; Ravindranath, T; Topaloglu, AK; Zeller, WP | 2 |
| Griffith, LG; Park, A; Wu, B | 1 |
| Cerra, FB; Gruetter, R; Nyberg, SL | 1 |
| Hwang, D; Lee, K; Stephanopoulos, G; Stephanopoulos, GN; Yarmush, ML; Yokoyama, T | 1 |
| Chen, MC; Huang, CT; Liang, HF; Sung, HW; Yang, TF | 1 |
| Agusti, A; Boix, J; Cauli, O; Cerdán, S; Felipo, V; López-Larrubia, P; Nieto-Charques, L; Rodrigo, R | 1 |
| Ai, Q; Ao, JE; Duan, R; Ge, P; Gong, X; Lin, L; Zhang, L | 1 |
| Guo, Z; Jiao, Y; Muhammad, N; Wang, K; Wang, X; Zhu, C; Zhu, Z | 1 |
| Bergère, M; Berjaud, C; Darmon, A; Germain, M; Levy, L; Paolini, M; Pottier, A; Poul, L; Vibert, E | 1 |
| Li, S; Lin, H; Siu, FY; Ye, S | 1 |
15 other study(ies) available for galactosamine and lactic acid
| Article | Year |
|---|---|
Biochemical effects of acute stress on energy metabolism in liver damaged rats.
Topics: Acetyl Coenzyme A; Animals; Chemical and Drug Induced Liver Injury; Cyclic AMP; Cyclic GMP; Energy Metabolism; Galactosamine; Ketone Bodies; Lactates; Lactic Acid; Liver Diseases; Male; Pyruvates; Pyruvic Acid; Rats; Rats, Inbred Strains; Stress, Physiological | 1987 |
Effects of polylactic acid microcapsules containing prostaglandin E2 on the survival rates of grade II coma galactosamine induced fulminant hepatic failure rats.
Topics: Animals; Capsules; Delayed-Action Preparations; Dinoprostone; Galactosamine; Hepatic Encephalopathy; Lactates; Lactic Acid; Male; Polyesters; Polymers; Prostaglandins E; Rats; Rats, Inbred Strains | 1987 |
Potential intercellular futile cycling of carbohydrates in diabetes.
Topics: Animals; Carbohydrate Metabolism; Diabetes Mellitus, Experimental; Extracellular Space; Female; Galactosamine; Gluconeogenesis; Ketone Bodies; Lactates; Lactic Acid; Liver; Oxygen Consumption; Perfusion; Rats; Rats, Inbred Strains; Tissue Distribution | 1987 |
Effect of galactosamine-induced hepatitis on the aerobic and anaerobic metabolism of the rat exposed to high-altitude hypoxia.
Topics: Aerobiosis; Altitude; Anaerobiosis; Animals; Citrate (si)-Synthase; Energy Metabolism; Fatty Acids; Fructose-Bisphosphatase; Fumarate Hydratase; Galactosamine; Glucosephosphate Dehydrogenase; Glutamate Dehydrogenase; Hepatitis, Animal; Hypoxia; Ketone Bodies; Lactates; Lactic Acid; Liver; Male; Mitochondria, Liver; Oxygen Consumption; Pyruvates; Pyruvic Acid; Rats; Rats, Sprague-Dawley | 1995 |
Galactosamine alters glucose regulation in ten-day-old rats treated with a low dose of endotoxin.
Topics: Adipose Tissue; Animals; Bacterial Toxins; Blood Glucose; Brain Chemistry; Endotoxins; Enterotoxins; Female; Galactosamine; Glucose; Hypoglycemia; Insulin; Lactates; Lactic Acid; Muscle, Skeletal; Pregnancy; Rats; Rats, Sprague-Dawley; Salmonella enteritidis | 1996 |
Integration of surface modification and 3D fabrication techniques to prepare patterned poly(L-lactide) substrates allowing regionally selective cell adhesion.
Topics: 3T3 Cells; Absorption; Animals; Biocompatible Materials; Biomedical Engineering; Cell Adhesion; Galactosamine; Lactic Acid; Liver; Mice; Microscopy, Electron, Scanning; Molecular Structure; Poloxalene; Polyesters; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Propylene Glycols; Prostheses and Implants; Rats; Rats, Inbred Lew; Surface Properties; Surface-Active Agents | 1998 |
Brain lactate by magnetic resonance spectroscopy during fulminant hepatic failure in the dog.
Topics: Animals; Biomarkers; Brain; Dogs; Dose-Response Relationship, Drug; Feasibility Studies; Galactosamine; Glutamic Acid; Glutamine; Hepatic Encephalopathy; Intracranial Hypertension; Lactic Acid; Magnetic Resonance Spectroscopy; Male; Time Factors | 1998 |
Effects of hydrazine sulfate on galactosamine-sensitized endotoxic shock in ten-day-old rats.
Topics: Animals; Blood Glucose; Endotoxemia; Female; Galactosamine; Hydrazines; Lactic Acid; Rats; Rats, Sprague-Dawley | 1998 |
Identification of optimal classification functions for biological sample and state discrimination from metabolic profiling data.
Topics: Algorithms; Amino Acids; Ammonia; Animals; Biomarkers; Diagnosis, Computer-Assisted; Galactosamine; Glucose; Ketone Bodies; Lactic Acid; Liver Failure; Male; Metabolic Clearance Rate; Models, Biological; Models, Statistical; Multivariate Analysis; Organ Specificity; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Urea | 2004 |
Preparation of nanoparticles composed of poly(gamma-glutamic acid)-poly(lactide) block copolymers and evaluation of their uptake by HepG2 cells.
Topics: Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Fluorescent Dyes; Galactosamine; Humans; Hydrolysis; Lactic Acid; Light; Liver Neoplasms; Magnetic Resonance Spectroscopy; Microscopy, Atomic Force; Microscopy, Confocal; Microscopy, Electron, Transmission; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rhodamine 123; Scattering, Radiation; Spectrometry, Fluorescence; Spectroscopy, Fourier Transform Infrared; Surface Properties | 2005 |
Brain region-selective mechanisms contribute to the progression of cerebral alterations in acute liver failure in rats.
Topics: Ammonia; Animals; Blood-Brain Barrier; Brain Edema; Capillary Permeability; Cerebellum; Cerebrum; Encephalocele; Galactosamine; Glutamine; Intracranial Hypertension; Lactic Acid; Liver Failure, Acute; Male; Rats; Rats, Wistar | 2011 |
Metformin suppresses intrahepatic coagulation activation in mice with lipopolysaccharide/D‑galactosamine‑induced fulminant hepatitis.
Topics: Animals; Anti-Inflammatory Agents; Blood Coagulation; Disease Models, Animal; Erythropoietin; Galactosamine; Hepatitis; Hypoglycemic Agents; Hypoxia-Inducible Factor 1, alpha Subunit; Inflammation; Interleukin-6; Lactic Acid; Lipopolysaccharides; Liver; Matrix Metalloproteinase 3; Metformin; Mice; NF-kappa B; Plasminogen Activator Inhibitor 1; RNA, Messenger; Thromboplastin; Up-Regulation; Vascular Endothelial Growth Factor A | 2015 |
Dual-drug loaded nanoformulation with a galactosamine homing moiety for liver-targeted anticancer therapy.
Topics: alpha-Tocopherol; Antineoplastic Agents; Caspase 3; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Liberation; Galactosamine; Humans; Lactic Acid; Liver Neoplasms; Nanoparticles; Platinum; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prodrugs; Reactive Oxygen Species | 2016 |
Nano-sized cytochrome P450 3A4 inhibitors to block hepatic metabolism of docetaxel.
Topics: Animals; Antineoplastic Agents; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Docetaxel; Drug Carriers; Female; Furocoumarins; Galactosamine; Hepatocytes; Humans; Inactivation, Metabolic; Lactic Acid; Liver; Mice, Nude; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Taxoids; Tissue Distribution | 2017 |
Galactosylated PLGA nanoparticles for the oral delivery of resveratrol: enhanced bioavailability and in vitro anti-inflammatory activity.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Biological Availability; Caco-2 Cells; Drug Liberation; Endocytosis; Galactosamine; Humans; Inflammation; Intestinal Absorption; Intestinal Mucosa; Lactic Acid; Male; Nanoparticles; Particle Size; Permeability; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Proton Magnetic Resonance Spectroscopy; Rats, Sprague-Dawley; Resveratrol; Solubility; Stilbenes | 2018 |